top of page

CHD Research

As a foundation we believe strongly in giving our resources to not only families whose children are dealing with Congenital Heart Defects but also to those who are researching to eradicate Congenital Heart Defects. The funds raised by Charlie Girl Foundation will be used to sponsor heart families and also will be given to the following organizations to be used towards research for pediatric heart disease.

Pipetting Samples

Research is vital to improving outcomes in pediatric cardiology. Due to advances in care chances are better than ever that cardiac diagnoses can be addressed and a normal life will follow. One in 120 births involve a baby with a congenital heart defect. Thirty years ago, a child born with a serious pediatric heart defect was not likely to survive. Fifteen years ago, for the first time, survivors outnumbered children born with cardiac defects. Research-driven advances in medication, surgical techniques, treatment options and care plans have helped make this possible.
Children’s is engaged in many types of research, including investigator-initiated studies (led by a Children’s clinician), as well as externally-sponsored multicenter trials, observational studies and registries. In their Cardiovascular and Critical Care program alone, there are over 50 ongoing research projects. Their cardiovascular team also actively publishes research and articles. In the past 10 years, more than 40 articles have been published in peer reviewed publications.
An essential component of Children’s vision to be every family’s essential partner in raising healthier children is our commitment to generate, apply and share new knowledge. This commitment makes our cardiovascular program’s outcomes consistently among the best in the nation.

Taking Samples

University of Minnesota Masonic Children’s Hospital is home to physician-researchers and pediatric specialists who are global leaders in children’s health research, education and care. They accelerate breakthrough discoveries to treat and cure childhood disease. The University of Minnesota leads the way in some of the 20th century’s greatest advances in cardiovascular health and has made a dramatic difference in the treatment of children born with heart defects. University of Minnesota physicians performed the world’s first successful open-heart surgery, and its scientists created the first wearable pacemaker. Through pioneering treatments and novel approaches, cardiovascular innovations are contributing to increased life expediencies and quality of life for children with congenial heart disease and other cardiovascular conditions.

Research: Programs
bottom of page